+44 330 822 4832
+44 330 822 4832
Like us on:
organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 91³Ô¹Ï Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
91³Ô¹Ï Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Articles published in Epidemiology: 91³Ô¹Ï have been cited by esteemed scholars and scientists all around the world. Epidemiology: 91³Ô¹Ï has got h-index 22, which means every article in Epidemiology: 91³Ô¹Ï has got 22 average citations.
Following are the list of articles that have cited the articles published in Epidemiology: 91³Ô¹Ï.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
Total published articles |
40 | 50 | 61 | 62 | 31 | 20 | 29 | 51 | 66 |
Research, Review articles and Editorials |
17 | 40 | 36 | 15 | 17 | 12 | 0 | 0 | 0 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
0 | 2 | 7 | 16 | 2 | 0 | 0 | 0 | 0 |
Conference proceedings |
0 | 5 | 0 | 0 | 0 | 0 | 47 | 64 | 61 |
Citations received as per Google Scholar, other indexing platforms and portals |
413 | 486 | 526 | 526 | 480 | 428 | 271 | 226 | 181 |
| Journal total citations count | 3864 |
| Journal impact factor | 10.58 |
| Journal 5 years impact factor | 10.09 |
| Journal cite score | 10.22 |
| Journal h-index | 22 |
| Journal h-index since 2019 | 18 |
 |
Description of the Risk Management of Medication Errors for Centrally Authorised Products in the European Union |
| | | | |
|
Quit Smoke or Quit Your Life With Stroke! |
| | | | |
|
Using Clinical Databases to Verify the Impact of Regulatory Agency Alerts in Japan: Hepatitis B Testing Behavior After an Alert Regarding Risk of Viral Reactivation |
| | | | |
|
Prevalence and predictors of midwakh smoking among male students of Qassim University, Al-Qassim, Saudi Arabia |
| | | | |
|
An Evaluation of the Effectiveness of Risk Minimization Measures for Tigecycline in the European Union |
| | | | |
|
Incidence and mortality of pancreatic cancer on a rapid rise in Taiwan, 1999–2012 |
| | | | |
|
Cancer Incidence in a Nationwide HIV/AIDS Patient Cohort in Taiwan in 1998–2009 |
| | | | |
|
Evaluation of the effectiveness of risk minimization measures for trimetazidine: A cross sectional joint PASS survey among physicians in selected European countries |
| | | | |
|
Clinical worthlessness of genetic prediction of common forms of diabetes mellitus and related chronic complications: A position statement of the Italian Society of Diabetology |
| | | | |
|
Periodic Benefit-Risk Evaluation Report: A European Union Regulatory Perspective |
| | | | |
|
Quality of Reporting on the Evaluation of Risk Minimization Programs: A Systematic Review |
| | | | |
|
The effectiveness of direct to healthcare professional communication – A systematic review of communication factor studies |
| | | | |
|
Assessment of Self-Administration of Romiplostim in Patients with Immune Thrombocytopenic Purpura after Receipt of Home Administration Training Materials: a Cross-Sectional Study |
| | | | |
|
Study design, process and outcome indicators of post-authorization studies aimed at evaluating the effectiveness of risk minimization measures in the EU PAS Register |
| | | | |
|
Recent Developments in EU and US Pharmacovigilance Legislation |
| | | | |
|
A comparison of pregnancy prevention programmes in Europe |
| | | | |
|
Measuring the Effectiveness of Safety Warnings on the Risk of Stroke in Older Antipsychotic Users: A Nationwide Cohort Study in Two Large Electronic Medical Records Databases in the United Kingdom and Italy |
| | | | |
|
Evaluation of Risk-Minimization Activities for Cyproterone Acetate 2 mg/Ethinylestradiol 35 µg: A Cross-Sectional Physician Survey |
| | | | |
|
The Additional Value of an E-Mail to Inform Healthcare Professionals of a Drug Safety Issue: A Randomized Controlled Trial in the Netherlands |
| | | | |
|
A descriptive review of additional risk minimisation measures applied to EU centrally authorised medicines 2006-2015 |
| | | | |
Make the best use of Scientific Research and information from our 700 + peer reviewed, 91³Ô¹Ï Journals
